CYCLOSET

Product NDC: 73515-123
11-digit product format: 735150123
Labeler code: 73515
Product ID: 73515-123_d584b098-e98a-4453-aa48-9d79a470036c
Type: HUMAN PRESCRIPTION DRUG
Nonproprietary name: bromocriptine mesylate
Dosage form: TABLET
Route: ORAL
Labeler: Avvisto Therapeutics LLC
Application: NDA020866
Marketing category: NDA
Marketing start: 2024-05-23
Substance: BROMOCRIPTINE MESYLATE
Active strength: .8 mg/1
Pharmacologic classes: Ergolines [CS], Ergot Derivative [EPC]
NDC exclude flag: No
Listing certified through: 2027-12-31
Current FDA listing: Yes

Source provenance: Browse the complete Orange Book source catalog · source snapshot 1.

Orange Book products#

Current product rows page 1 of 1 · 1 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	TE codes	RLD / RS	Approval date
N020866-001	CYCLOSET	BROMOCRIPTINE MESYLATE	EQ 0.8MG BASE	TABLET / ORAL		RLD, RS	2009-05-05

Orange Book patents#

Current patent rows page 1 of 2 · 126 matching rows.

Application-product, Patent, Expiration table
Application-product	Patent	Expiration	Use code	Coverage / status	Submission date
N020866-001	10688155	2030-06-07	U-2281		2020-08-18
N020866-001	10688155	2030-06-07	U-2890		2020-08-18
N020866-001	10688155	2030-06-07	U-2891		2020-08-18
N020866-001	10688155	2030-06-07	U-2892		2020-08-18
N020866-001	10688155	2030-06-07	U-2893		2020-08-18
N020866-001	10688155	2030-06-07	U-2894		2020-08-18
N020866-001	10688155	2030-06-07	U-2895		2020-08-18
N020866-001	10688155	2030-06-07	U-2896		2020-08-18
N020866-001	10688155	2030-06-07	U-2897		2020-08-18
N020866-001	10688155	2030-06-07	U-2898		2020-08-18
N020866-001	10688155	2030-06-07	U-2899		2020-08-18
N020866-001	10688155	2030-06-07	U-2900		2020-08-18
N020866-001	10688155	2030-06-07	U-2901		2020-08-18
N020866-001	10688155	2030-06-07	U-2902		2020-08-18
N020866-001	10688155	2030-06-07	U-2903		2020-08-18
N020866-001	10688155	2030-06-07	U-2904		2020-08-18
N020866-001	10688155	2030-06-07	U-2905		2020-08-18
N020866-001	10688155	2030-06-07	U-2906		2020-08-18
N020866-001	10688155	2030-06-07	U-2907		2020-08-18
N020866-001	10688155	2030-06-07	U-2908		2020-08-18
N020866-001	10688155	2030-06-07	U-2909		2020-08-18
N020866-001	10688155	2030-06-07	U-2910		2020-08-18
N020866-001	10688155	2030-06-07	U-2911		2020-08-18
N020866-001	10688155	2030-06-07	U-2912		2020-08-18
N020866-001	10688155	2030-06-07	U-2913		2020-08-18
N020866-001	10688155	2030-06-07	U-2914		2020-08-18
N020866-001	10688155	2030-06-07	U-2915		2020-08-18
N020866-001	10688155	2030-06-07	U-2916		2020-08-18
N020866-001	10688155	2030-06-07	U-2917		2020-08-18
N020866-001	10688155	2030-06-07	U-2918		2020-08-18
N020866-001	10688155	2030-06-07	U-2919		2020-08-18
N020866-001	10688155	2030-06-07	U-2920		2020-08-18
N020866-001	10688155	2030-06-07	U-2921		2020-08-18
N020866-001	10688155	2030-06-07	U-2922		2020-08-18
N020866-001	10688155	2030-06-07	U-2923		2020-08-18
N020866-001	10688155	2030-06-07	U-2924		2020-08-18
N020866-001	10688155	2030-06-07	U-2925		2020-08-18
N020866-001	10688155	2030-06-07	U-2926		2020-08-18
N020866-001	10688155	2030-06-07	U-2927		2020-08-18
N020866-001	10688155	2030-06-07	U-2928		2020-08-18
N020866-001	10688155	2030-06-07	U-2929		2020-08-18
N020866-001	10688155	2030-06-07	U-2930		2020-08-18
N020866-001	10688155	2030-06-07	U-2931		2020-08-18
N020866-001	10688155	2030-06-07	U-2932		2020-08-18
N020866-001	10688155	2030-06-07	U-2933		2020-08-18
N020866-001	10688155	2030-06-07	U-2934		2020-08-18
N020866-001	10688155	2030-06-07	U-2935		2020-08-18
N020866-001	10688155	2030-06-07	U-2936		2020-08-18
N020866-001	10688155	2030-06-07	U-2937		2020-08-18
N020866-001	8877708	2030-06-07	U-1706	Drug product	2015-06-18
N020866-001	9352025	2030-06-07	U-2111		2017-09-27
N020866-001	9352025	2030-06-07	U-2112		2017-09-27
N020866-001	9352025	2030-06-07	U-2113		2017-09-27
N020866-001	9352025	2030-06-07	U-2114		2017-09-27
N020866-001	9352025	2030-06-07	U-2115		2017-09-27
N020866-001	9352025	2030-06-07	U-2116		2017-09-27
N020866-001	9352025	2030-06-07	U-2117		2017-09-27
N020866-001	9352025	2030-06-07	U-2118		2017-09-27
N020866-001	9352025	2030-06-07	U-2119		2017-09-27
N020866-001	9895422	2030-06-07	U-2114		2018-05-07
N020866-001	9895422	2030-06-07	U-2116		2018-05-07
N020866-001	9895422	2030-06-07	U-2281		2018-05-07
N020866-001	9895422	2030-06-07	U-2282		2018-05-07
N020866-001	9895422	2030-06-07	U-2283		2018-05-07
N020866-001	9895422	2030-06-07	U-2284		2018-05-07
N020866-001	9895422	2030-06-07	U-2285		2018-05-07
N020866-001	9895422	2030-06-07	U-2286		2018-05-07
N020866-001	9895422	2030-06-07	U-2287		2018-05-07
N020866-001	10688094	2032-04-30	U-2870		2020-08-11
N020866-001	10688094	2032-04-30	U-2871		2020-08-11
N020866-001	10688094	2032-04-30	U-2872		2020-08-11
N020866-001	10688094	2032-04-30	U-2873		2020-08-11
N020866-001	10688094	2032-04-30	U-2874		2020-08-11
N020866-001	10688094	2032-04-30	U-2875		2020-08-11
N020866-001	10688094	2032-04-30	U-2876		2020-08-11
N020866-001	10688094	2032-04-30	U-2877		2020-08-11
N020866-001	10688094	2032-04-30	U-2878		2020-08-11
N020866-001	10688094	2032-04-30	U-2879		2020-08-11
N020866-001	10688094	2032-04-30	U-2880		2020-08-11
N020866-001	10688094	2032-04-30	U-2881		2020-08-11

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 2 · 41 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	RLD / RS	Approval date	Source SHA-256
2026-02-19 14:30 UTC	2026-02	N020866-001	CYCLOSET	EQ 0.8MG BASE	TABLET / ORAL	RLD, RS	2009-05-05	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N020866-001	CYCLOSET	EQ 0.8MG BASE	TABLET / ORAL	RLD, RS	2009-05-05	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	N020866-001	CYCLOSET	EQ 0.8MG BASE	TABLET / ORAL	RLD, RS	2009-05-05	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N020866-001	CYCLOSET	EQ 0.8MG BASE	TABLET / ORAL	RLD, RS	2009-05-05	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N020866-001	CYCLOSET	EQ 0.8MG BASE	TABLET / ORAL	RLD, RS	2009-05-05	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N020866-001	CYCLOSET	EQ 0.8MG BASE	TABLET / ORAL	RLD, RS	2009-05-05	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N020866-001	CYCLOSET	EQ 0.8MG BASE	TABLET / ORAL	RLD, RS	2009-05-05	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N020866-001	CYCLOSET	EQ 0.8MG BASE	TABLET / ORAL	RLD, RS	2009-05-05	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	N020866-001	CYCLOSET	EQ 0.8MG BASE	TABLET / ORAL	RLD, RS	2009-05-05	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	N020866-001	CYCLOSET	EQ 0.8MG BASE	TABLET / ORAL	RLD, RS	2009-05-05	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	N020866-001	CYCLOSET	EQ 0.8MG BASE	TABLET / ORAL	RLD, RS	2009-05-05	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	N020866-001	CYCLOSET	EQ 0.8MG BASE	TABLET / ORAL	RLD, RS	2009-05-05	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	N020866-001	CYCLOSET	EQ 0.8MG BASE	TABLET / ORAL	RLD, RS	2009-05-05	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	N020866-001	CYCLOSET	EQ 0.8MG BASE	TABLET / ORAL	RLD, RS	2009-05-05	`8072bd15b7f6…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	N020866-001	CYCLOSET	EQ 0.8MG BASE	TABLET / ORAL	RLD, RS	2009-05-05	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	N020866-001	CYCLOSET	EQ 0.8MG BASE	TABLET / ORAL	RLD, RS	2009-05-05	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	N020866-001	CYCLOSET	EQ 0.8MG BASE	TABLET / ORAL	RLD, RS	2009-05-05	`4b0b4de00fa7…`
2019-12-13 00:20 UTC	2019-12	N020866-001	CYCLOSET	EQ 0.8MG BASE	TABLET / ORAL	RLD, RS	2009-05-05	`74a2ff9319b5…`
2022-03-09 01:35 UTC	2022-03	N020866-001	CYCLOSET	EQ 0.8MG BASE	TABLET / ORAL	RLD, RS	2009-05-05	`bb7c543d1eb4…`
2021-12-28 21:50 UTC	2021-12	N020866-001	CYCLOSET	EQ 0.8MG BASE	TABLET / ORAL	RLD, RS	2009-05-05	`782e0a99824c…`
2021-05-05 16:15 UTC · 3 captures of this ZIP	2021-05	N020866-001	CYCLOSET	EQ 0.8MG BASE	TABLET / ORAL	RLD, RS	2009-05-05	`87673890dc5c…`
2021-03-12 10:30 UTC	2021-03	N020866-001	CYCLOSET	EQ 0.8MG BASE	TABLET / ORAL	RLD, RS	2009-05-05	`5aa47cf7b7d7…`
2020-12-22 03:56 UTC	2020-12	N020866-001	CYCLOSET	EQ 0.8MG BASE	TABLET / ORAL	RLD, RS	2009-05-05	`8869cabd3fbd…`
2020-11-12 02:37 UTC	2020-11	N020866-001	CYCLOSET	EQ 0.8MG BASE	TABLET / ORAL	RLD, RS	2009-05-05	`c0c555d07b60…`
2019-12-14 00:12 UTC	2019-12	N020866-001	CYCLOSET	EQ 0.8MG BASE	TABLET / ORAL	RLD, RS	2009-05-05	`3f01610625f2…`
2019-09-15 20:21 UTC	2019-09	N020866-001	CYCLOSET	EQ 0.8MG BASE	TABLET / ORAL	RLD, RS	2009-05-05	`b00525d2431f…`
2019-07-19 19:46 UTC	2019-07	N020866-001	CYCLOSET	EQ 0.8MG BASE	TABLET / ORAL	RLD, RS	2009-05-05	`ea99ee380514…`
2024-03-16 18:09 UTC · 4 captures of this ZIP	2024-03	N020866-001	CYCLOSET	EQ 0.8MG BASE	TABLET / ORAL	RLD, RS	2009-05-05	`6a51e52b5d6a…`
2024-02-18 07:12 UTC	2024-02	N020866-001	CYCLOSET	EQ 0.8MG BASE	TABLET / ORAL	RLD, RS	2009-05-05	`1c564ffb4f44…`
2023-12-20 04:57 UTC	2023-12	N020866-001	CYCLOSET	EQ 0.8MG BASE	TABLET / ORAL	RLD, RS	2009-05-05	`ea1830bbd6c7…`
2023-11-28 05:40 UTC · 2 captures of this ZIP	2023-11	N020866-001	CYCLOSET	EQ 0.8MG BASE	TABLET / ORAL	RLD, RS	2009-05-05	`a72a2bbeb626…`
2023-10-25 00:34 UTC · 2 captures of this ZIP	2023-10	N020866-001	CYCLOSET	EQ 0.8MG BASE	TABLET / ORAL	RLD, RS	2009-05-05	`9b2671bbb829…`
2023-07-15 15:27 UTC · 2 captures of this ZIP	2023-07	N020866-001	CYCLOSET	EQ 0.8MG BASE	TABLET / ORAL	RLD, RS	2009-05-05	`a67488948f0b…`
2023-06-13 01:57 UTC · 3 captures of this ZIP	2023-06	N020866-001	CYCLOSET	EQ 0.8MG BASE	TABLET / ORAL	RLD, RS	2009-05-05	`3f0d92c62455…`
2023-05-13 08:27 UTC	2023-05	N020866-001	CYCLOSET	EQ 0.8MG BASE	TABLET / ORAL	RLD, RS	2009-05-05	`053a50430f4f…`
2023-01-26 05:58 UTC	2023-01	N020866-001	CYCLOSET	EQ 0.8MG BASE	TABLET / ORAL	RLD, RS	2009-05-05	`3bdfa0b2c4d7…`
2022-11-12 20:34 UTC · 5 captures of this ZIP	2022-11	N020866-001	CYCLOSET	EQ 0.8MG BASE	TABLET / ORAL	RLD, RS	2009-05-05	`3a93d1ddd44b…`
2022-10-28 04:53 UTC	2022-10	N020866-001	CYCLOSET	EQ 0.8MG BASE	TABLET / ORAL	RLD, RS	2009-05-05	`f41ea6bd6efb…`
2022-09-29 23:25 UTC	2022-09	N020866-001	CYCLOSET	EQ 0.8MG BASE	TABLET / ORAL	RLD, RS	2009-05-05	`e64feba35796…`
2022-07-09 03:26 UTC · 3 captures of this ZIP	2022-07	N020866-001	CYCLOSET	EQ 0.8MG BASE	TABLET / ORAL	RLD, RS	2009-05-05	`cb3db0bc1861…`

Observed Orange Book patent history#

Patent history page 1 of 121 · 4,830 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Patent	Expiration	Use code	Submission date	Source SHA-256
2026-02-19 14:30 UTC	2026-02	N020866-001	10688155	2030-06-07	U-2898	2020-08-18	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N020866-001	10688155	2030-06-07	U-2905	2020-08-18	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N020866-001	10688155	2030-06-07	U-2902	2020-08-18	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N020866-001	10688155	2030-06-07	U-2890	2020-08-18	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N020866-001	10688155	2030-06-07	U-2914	2020-08-18	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N020866-001	10688155	2030-06-07	U-2911	2020-08-18	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N020866-001	10688155	2030-06-07	U-2903	2020-08-18	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N020866-001	10688155	2030-06-07	U-2281	2020-08-18	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N020866-001	10688155	2030-06-07	U-2901	2020-08-18	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N020866-001	10688155	2030-06-07	U-2912	2020-08-18	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N020866-001	10688155	2030-06-07	U-2891	2020-08-18	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N020866-001	10688155	2030-06-07	U-2896	2020-08-18	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N020866-001	10688155	2030-06-07	U-2893	2020-08-18	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N020866-001	10688155	2030-06-07	U-2899	2020-08-18	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N020866-001	10688155	2030-06-07	U-2904	2020-08-18	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N020866-001	10688155	2030-06-07	U-2900	2020-08-18	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N020866-001	10688155	2030-06-07	U-2906	2020-08-18	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N020866-001	10688155	2030-06-07	U-2908	2020-08-18	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N020866-001	10688155	2030-06-07	U-2913	2020-08-18	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N020866-001	10688155	2030-06-07	U-2894	2020-08-18	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N020866-001	10688155	2030-06-07	U-2910	2020-08-18	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N020866-001	10688155	2030-06-07	U-2892	2020-08-18	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N020866-001	10688155	2030-06-07	U-2895	2020-08-18	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N020866-001	10688155	2030-06-07	U-2909	2020-08-18	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N020866-001	10688155	2030-06-07	U-2897	2020-08-18	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N020866-001	10688155	2030-06-07	U-2907	2020-08-18	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N020866-001	10688155	2030-06-07	U-2936	2020-08-18	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N020866-001	10688155	2030-06-07	U-2915	2020-08-18	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N020866-001	10688155	2030-06-07	U-2935	2020-08-18	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N020866-001	10688155	2030-06-07	U-2932	2020-08-18	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N020866-001	10688155	2030-06-07	U-2924	2020-08-18	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N020866-001	10688155	2030-06-07	U-2926	2020-08-18	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N020866-001	10688155	2030-06-07	U-2931	2020-08-18	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N020866-001	10688155	2030-06-07	U-2927	2020-08-18	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N020866-001	10688155	2030-06-07	U-2918	2020-08-18	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N020866-001	10688155	2030-06-07	U-2933	2020-08-18	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N020866-001	10688155	2030-06-07	U-2916	2020-08-18	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N020866-001	10688155	2030-06-07	U-2920	2020-08-18	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N020866-001	10688155	2030-06-07	U-2922	2020-08-18	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N020866-001	10688155	2030-06-07	U-2921	2020-08-18	`011fe1cb6892…`

Additional Listing Data#

Finished product: Yes
Brand name base: CYCLOSET
Listing expiration: 2027-12-31

Active Ingredients#

Ingredient, Strength table
Ingredient	Strength
BROMOCRIPTINE MESYLATE	.8 mg/1

Harmonized UNII identifiers#

UNII identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
FFP983J3OD	Internal UNII lookup

Harmonized RxCUI identifiers#

RxCUI identifiers page 1 of 1 · 2 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
859077	Internal RxNorm lookup
859081	Internal RxNorm lookup

Harmonized SPL set identifiers#

SPL set identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
e42ba916-16b9-4d1c-8d09-9d2fbb1b6c20	Available on FDA.report

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
90f4f2b3-d032-9eaf-93c5-f165b5a4c90e	Product name	1	20140508

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	Strength	SPL version
73515-123-21	CYCLOSET	21 in 1 BOTTLE	TABLET	21		7
73515-123-30	CYCLOSET	200 in 1 BOTTLE	TABLET	200		7

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
73515-123-30	EA - Each	73515-123	25abe12e-318b-4ed1-9fa4-2fa57635a679	1	2024-10-04

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
73515-123	CYCLOSET (BROMOCRIPTINE MESYLATE) TABLET [AVVISTO THERAPEUTICS LLC]	6	Current NDC, 2 package rows	20241027_e42ba916-16b9-4d1c-8d09-9d2fbb1b6c20.zip

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
CYCLOSET	BROMOCRIPTINE MESYLATE	Avvisto Therapeutics LLC	e42ba916-16b9-4d1c-8d09-9d2fbb1b6c20	2026-01-12	Warnings, Adverse reactions	Exact identifier application applno (NDA): 020866 application number: NDA020866 ndc (product): 73515-123

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
FFP983J3OD	BROMOCRIPTINE MESYLATE	22260-51-1	BROMOCRIPTINE MESYLATE

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	DailyMed	SPL version
859077	bromocriptine mesylate 0.8 MG Oral Tablet	PSN	e42ba916-16b9-4d1c-8d09-9d2fbb1b6c20	7
859081	CYCLOSET 0.8 MG Oral Tablet	PSN	e42ba916-16b9-4d1c-8d09-9d2fbb1b6c20	7
859081	bromocriptine 0.8 MG Oral Tablet [Cycloset]	SBD	e42ba916-16b9-4d1c-8d09-9d2fbb1b6c20	7
859077	bromocriptine 0.8 MG Oral Tablet	SCD	e42ba916-16b9-4d1c-8d09-9d2fbb1b6c20	7
859081	Cycloset 0.8 MG Oral Tablet	SY	e42ba916-16b9-4d1c-8d09-9d2fbb1b6c20	7

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Units	Marketing start	Sample	Exclude flag	Status
73515-123-21	73515012321	21 TABLET in 1 BOTTLE (73515-123-21)	21 tablet	2024-05-23	No	No	Current
73515-123-30	73515012330	200 TABLET in 1 BOTTLE (73515-123-30)	200 tablet	2024-05-23	No	No	Current

Title, Manufacturer, Effective date table
Title	Manufacturer	Effective date	Type	Version
CYCLOSET	Avvisto Therapeutics LLC \| Patheon Pharmaceuticals Inc. \| AMRI Italy S.r.l.	2026-01-12	HUMAN PRESCRIPTION DRUG LABEL	7